Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 19/20 | 0.65 |
| ▸ | CDK9 | P50750 | 15/20 | 0.65 |
| ▸ | CDK1 | P06493 | 8/20 | 0.65 |
| ▸ | CDK4 | P11802 | 7/20 | 0.65 |
| ▸ | AURKA | O14965 | 6/20 | 0.65 |
| ▸ | AURKB | Q96GD4 | 6/20 | 0.65 |
| ▸ | CCNA2 | P20248 | 12/20 | 0.62 |
| ▸ | CCNT1 | O60563 | 11/20 | 0.62 |
| ▸ | WEE1 | P30291 | 3/20 | 0.53 |
| ▸ | CDK6 | Q00534 | 3/20 | 0.53 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.53 |
| ▸ | DAPK3 | O43293 | 2/20 | 0.53 |
| ▸ | JAK2 | O60674 | 2/20 | 0.53 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.53 |
| ▸ | PAK4 | O96013 | 2/20 | 0.53 |
| ▸ | ABL1 | P00519 | 2/20 | 0.53 |
| ▸ | FYN | P06241 | 2/20 | 0.53 |
| ▸ | CSF1R | P07333 | 2/20 | 0.53 |
| ▸ | RET | P07949 | 2/20 | 0.53 |
| ▸ | MET | P08581 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6159448 | 0.81 | CDK2 (0.48) | CDK2CDK9CDK1CDK4AURKA | |
| SCHEMBL4164374 | 0.79 | CDK2 (0.79) | CDK2CDK9CDK1CDK4AURKA | |
| SCHEMBL2075969 | 0.79 | CDK2 (1.00) | CDK2CDK9CDK1CDK4AURKA | |
| SCHEMBL29815829 | 0.76 | CDK4 (0.82) | CDK2CDK9CDK1CDK4AURKA | |
| SCHEMBL18480846 | 0.76 | CDK4 (0.82) | CDK2CDK9CDK1CDK4AURKA | |
| SCHEMBL5245816 | 0.72 | CDK2 (0.64) | CDK2CDK9CDK1CDK4AURKA | |
| SCHEMBL4161891 | 0.70 | CDK2 (0.80) | CDK2CDK9CDK1CDK4AURKA | |
| Cyc-116 SCHEMBL2074998 | 0.69 | CDK2 (1.00) | CDK2CDK9CDK1CDK4AURKA | |
| Cyc-116 SCHEMBL29366353 | 0.69 | CDK2 (1.00) | CDK2CDK9CDK1CDK4AURKA | |
| SCHEMBL4169064 | 0.69 | CDK2 (0.68) | CDK2CDK9CDK1CDK4AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050192300-A1 | Pyrimidine compounds | CYCLACEL LIMITED (GB) | 2005-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050192300-A1 | Pyrimidine compounds | CDK2, CCNI, CDK6 | CDK2 1/4885CDK9 5/4885CDK1 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.